Xiao-Ting Yue
Impact in
-
- Cardiovascular Disease and Adiposity
Papers in
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 4
- Peptidase Inhibition and Analysis 1
-
- Cardiovascular Function and Risk Factors 2
- Co-authors
- Junnan Tang (14 shared papers)Jinying Zhang (13 shared papers)Qianqian Guo (12 shared papers)Jianchao Zhang (12 shared papers)Ying‐Ying Zheng (9 shared papers)Lei Fan (9 shared papers)Rujie Zheng (11 shared papers)Zhiyu Liu (10 shared papers)
- Journals
- Bioscience Reports (3 papers)Coronary Artery Disease (1 paper)Journal of Interventional Cardiology (1 paper)Lipids in Health and Disease (1 paper)Bioactive Materials (1 paper)
- Partner nations
- China
In The Last Decade
Xiao-Ting Yue
13 papers receiving 162 citations
Peers
Comparison fields: 5 of 50
- Nephrology 10
- Cardiology and Cardiovascular Medicine 22
- Oncology 25
- Cancer Research 13
- Endocrinology, Diabetes and Metabolism 10
Countries citing papers authored by Xiao-Ting Yue
This map shows the geographic impact of Xiao-Ting Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Ting Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Ting Yue more than expected).
Fields of papers citing papers by Xiao-Ting Yue
This network shows the impact of papers produced by Xiao-Ting Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Ting Yue. The network helps show where Xiao-Ting Yue may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-Ting Yue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 29 | |
| 2 | 2021 | 23 | |
| 3 | 2021 | 18 | |
| 4 | 2021 | 16 | |
| 5 | 2023 | 16 | |
| 6 | 2019 | 14 | |
| 7 | 2020 | 11 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2022 | 6 | |
| 12 | 2020 | 3 | |
| 13 | 2022 | 1 | |
| 14 | 2020 | 0 | |
| 15 | 2019 | 0 |
About Xiao-Ting Yue
Xiao-Ting Yue is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 164 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (4 papers), Cardiovascular Function and Risk Factors (2 papers), Blood properties and coagulation (1 paper), Peptidase Inhibition and Analysis (1 paper), Coronary Interventions and Diagnostics (1 paper), Diabetes Treatment and Management (1 paper), Circular RNAs in diseases (1 paper) and Cardiac Structural Anomalies and Repair (1 paper). The work is most often cited by research in Nephrology (10 citations), Cardiology and Cardiovascular Medicine (22 citations), Oncology (25 citations), Cancer Research (13 citations) and Endocrinology, Diabetes and Metabolism (10 citations). Xiao-Ting Yue has collaborated with scholars based in China. Frequent co-authors include Junnan Tang, Jinying Zhang, Qianqian Guo, Jianchao Zhang, Ying‐Ying Zheng, Lei Fan, Rujie Zheng, Zhiyu Liu, Kai Wang and Chang Cao. Their work appears in journals such as Bioscience Reports, Coronary Artery Disease, Journal of Interventional Cardiology, Lipids in Health and Disease and Bioactive Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.